We are live on ! Find out more
NSRX

Nasus Pharma
NSRX

9 hedge funds and large institutions have $4.83M invested in Nasus Pharma in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22,082% more capital invested

Capital invested by funds: $21.8K → $4.83M (+$4.8M)

350% more funds holding

Funds holding: 2 → 9 (+7)

18.57% more ownership

Funds ownership: 0% → 18.57% (+19%)

Holders
9
Holders Change
+7
Holders Change %
+350%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$4.64M
2
CCC
Cable Car Capital
California
+$3.11M
3
VCIM
Velan Capital Investment Management
Georgia
+$1.86M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$696K
5
BL
Bleichroeder LP
New York
+$464K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Balyasny Asset Management
1
Balyasny Asset Management
Illinois
$1.99M +$4.64M +898,473 New
CCC
2
Cable Car Capital
California
$1.34M +$3.11M +601,998 New
VCIM
3
Velan Capital Investment Management
Georgia
$798K +$1.86M +359,390 New
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$299K +$696K +134,771 New
BL
5
Bleichroeder LP
New York
$199K +$464K +89,848 New
EAM
6
Empery Asset Management
New York
$102K +$236K +45,803 New
HF
7
HRT Financial
New York
$86K +$201K +38,897 New
UBS Group
8
UBS Group
Switzerland
$6.87K +$14K +2,716 +719%
Morgan Stanley
9
Morgan Stanley
New York
$4.44K – – –